Gross Examinations Versus Frozen Section for Assessment of Surgical Margins in Oral Cancers
Launched by DR.PANKAJ CHATURVEDI · Mar 19, 2021
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods for checking the edges of tumors in patients with oral cavity cancer to see which method is more effective. The two methods being compared are gross examination (where the surgeon visually inspects the area) and frozen section (a lab test that looks at the tissue immediately during surgery). The goal is to find out if the surgeon's visual inspection is just as good as the lab test for ensuring that all the cancer has been removed. Previous studies have shown that the frozen section may not significantly improve patient outcomes and can be expensive and hard to access in some places.
To participate in this trial, you need to be an adult over 18 years old with a confirmed diagnosis of oral cavity cancer who has not received any prior treatment. You should be scheduled for surgery to remove the tumor with a clear margin, meaning there’s healthy tissue around it. If you join the trial, you can expect to have your surgical margins assessed through either method, and researchers will monitor the outcomes to see which approach works best. This study is currently recruiting participants, and your involvement could help improve treatment strategies for future patients with oral cavity cancer.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Biopsy proven treatment naïve cases of OCSCC who are planned for curative surgery with en-bloc removal of the tumor with adequate margin
- • 2. In detail assessment of the primary tumor is possible pre-operatively
- • 3. Written informed consent
- • 4. Age more than 18 years
- Exclusion Criteria:
- • 1. Multifocal disease
- • 2. Clinically evident field cancerization
- • 3. Previous treatment for oral cavity cancer - Surgery /chemo or radiotherapy -
About Dr.Pankaj Chaturvedi
Dr. Pankaj Chaturvedi is a prominent clinical trial sponsor known for his commitment to advancing medical research and improving patient outcomes. With extensive expertise in oncology and a focus on innovative therapeutic strategies, Dr. Chaturvedi leads rigorous clinical trials that aim to evaluate new treatments and enhance existing protocols. His dedication to ethical standards and patient safety ensures that trials are conducted with the highest level of integrity, fostering collaboration among multidisciplinary teams. Through his initiatives, Dr. Chaturvedi contributes significantly to the development of effective healthcare solutions and the advancement of clinical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mumbai, Maharashtra, India
Navi Mumbai, Raigad, India
Varanasi, Uttar Pradesh, India
Patients applied
Trial Officials
Pankaj Chaturvedi, MS
Principal Investigator
Tata Memorial Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials